Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Journal of Stem Cells and Regenerative Medicine is Scopus-indexed (Q3, CiteScore 2.4), WoS ESCI, DOAJ. Published by M/S GN Corporation Co. Ltd.
Checked against the index lists dated .
ISSN 0973-7154Verify ISSN ↗
Publisher: M/S GN Corporation Co. Ltd
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Biotechnology | 219 / 325 | 32nd | Q3 |
| Biochemistry | 345 / 448 | 23rd | Q4 |
| Molecular Biology | 338 / 414 | 18th | Q4 |
| Cell Biology | 253 / 289 | 12th | Q4 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2010–present, best quartile Q3, CiteScore 2.4.
Journal of Stem Cells and Regenerative Medicine is Q3 in Biotechnology (rank 219 of 325), Q4 in Biochemistry (rank 345 of 448) and Q4 in Molecular Biology (rank 338 of 414), by CiteScore 2025. It is ranked in 4 subject areas in all.
Journal of Stem Cells and Regenerative Medicine is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 2.4, which places it in quartile Q3 at the 32nd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.334, quartile Q3, with an H-index of 21.
The publisher lists an article processing charge of about US$380 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Journal of Stem Cells and Regenerative Medicine is published by M/S GN Corporation Co. Ltd. Its ISSN is 0973-7154.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Journal of Stem Cells and Regenerative Medicine has an h-index of 24 and a 2-year mean of 0.7 citations per paper (OpenAlex). Its Scopus CiteScore is 2.4, quartile Q3. On 2-year citations it ranks #239 of 309 Scopus journals in Biotechnology.
Journal of Stem Cells and Regenerative Medicine published 15 papers in 2025; its busiest recent year was 2018 with 17. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 40 research articles (2021–2026), authors are most often from Japan (21.3%), Iran (15%) and Indonesia (12.5%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.